NCT07328789

Brief Summary

Cardiovascular diseases, especially after life-saving surgeries, require comprehensive cardiac rehabilitation (CR). We know that the effectiveness of CR varies among patients. The main goal of this study is to understand which factors-psychological, physical, cognitive, biochemical, and hormonal-influence the success and long-term durability of the recovery process. These findings will help us create more effective and personalized treatment programs. Who is Being Studied and What is Being Assessed? Study Group: 150 patients of both sexes, aged 50-80 years, hospitalized in the cardiac rehabilitation ward, primarily after Coronary Artery Bypass Grafting (CABG). Study Period: Patients will be assessed at the start of their hospital stay, at the end of rehabilitation, and again 3-6 months after discharge. Key Assessment Areas (Modulating Factors) Physical Status and Fitness: Exercise tolerance (6-Minute Walk Test). Muscle strength (handgrip), balance, and gait. Body composition (analysis of muscle mass and fat tissue). Respiratory function and diaphragm mobility (ultrasound). Psychological and Cognitive Factors: Assessment of anxiety, depression, and general mental well-being. Evaluation of cognitive functions (memory, concentration) following cardiac surgery. Sleep Problems (OSA): Assessment of the risk and severity of Obstructive Sleep Apnea (OSA), which is common in cardiac patients. Analysis of OSA risk factors related to oral health (dentition, microbiome) and craniofacial structure. Biological Markers: Hormonal tests (e.g., testosterone, estradiol) and their correlation with psycho-physical condition and the rehabilitation process. Analysis of metabolic and muscle-related biomarkers (e.g., myokines: irisin, myostatin).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
39mo left

Started Jan 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Jan 2026Jul 2029

First Submitted

Initial submission to the registry

December 1, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

January 3, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2029

Expected
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Last Updated

January 9, 2026

Status Verified

December 1, 2025

Enrollment Period

3.5 years

First QC Date

December 1, 2025

Last Update Submit

January 8, 2026

Conditions

Keywords

Cardiac RehabilitationSex HormonesCognitive Dysfunction

Outcome Measures

Primary Outcomes (1)

  • Change in Physical Capacity (6MWT)

    Distance walked in 6 minutes measured in meters using the 6-Minute Walk Test (6MWT). The test reflects objective functional improvement in physical capacity.

    Baseline (start of hospitalization/T0) and Post-Rehab (end of cardiac rehabilitation/T1, approximately 3-4 weeks later)

Secondary Outcomes (5)

  • Change in Psychological Status (HADS)

    Baseline, Post-Rehab (approx. 3-4 weeks later), and Follow-up (3-6 months after discharge

  • Diaphragm Thickness

    Baseline and Post-Rehab (approx. 3-4 weeks later).

  • Change in Diaphragm Mobility

    Baseline and Post-Rehab (approx. 3-4 weeks later).

  • Change in Montreal Cognitive Assessment (MoCA) Score

    Baseline, Post-Rehab (approx. 3-4 weeks later), and Follow-up (3-6 months after discharge).

  • Change in Mini-Mental State Examination (MMSE) Score

    Baseline, Post-Rehab (approx. 3-4 weeks later), and Follow-up (3-6 months after discharge).

Other Outcomes (3)

  • Change in Apnea-Hypopnea Index (AHI)

    Baseline and Post-Rehab (approx. 3-4 weeks later).

  • Change in Sex Hormones Concentration

    Baseline (fasting) and Post-Rehab (fasting, approx. 3-4 weeks later)

  • Change in Myokines and Metabolic Markers Concentration

    Baseline (fasting) and Post-Rehab (fasting, approx. 3-4 weeks later).

Interventions

This study is an observational, non-pharmacological, multi-domain assessment of patients undergoing standard comprehensive cardiac rehabilitation (CR) following CABG surgery. The intervention involves a detailed, longitudinal, three-stage evaluation (Baseline, Post-Rehab, 3-6 Month Follow-up) of the factors influencing CR outcomes. The CR itself is a standard hospital-based program, but the research intervention is distinguished by its holistic focus on measuring and correlating: Objective Functional Data: Exercise capacity (6MWT), muscle strength, diaphragm function (USG), and postural stability. Multifactorial Co-morbidities: Screening for Obstructive Sleep Apnea (OSA) (NOX-T3), Cognitive Dysfunction (MoCA/MMSE), and the role of oral health in OSA risk. Biological \& Hormonal Profile: Measuring Sex Hormones (Testosterone, Estradiol) and Myokines (Irisin, Myostatin) to understand personalized metabolic and adaptive responses to the rehabilitation program. The intervention aims to

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male patients aged 50-80 years who have undergone coronary artery bypass graft (CABG) surgery and are currently hospitalized for cardiac rehabilitation. The study population includes individuals from a single clinical center in Poland.

You may qualify if:

  • Male patients aged 50-80 years
  • Hospitalization in the Cardiac Rehabilitation Ward
  • Undergone coronary artery bypass graft (CABG) surgery within the last 30 days
  • Written, informed consent to participate in the study

You may not qualify if:

  • Type II diabetes treated with insulin
  • Neuro-surgical operation in the last 6 months
  • Aneurysms of the cerebral arteries and aorta
  • Recurrent ischemic stroke (Cerebral Vascular Accident)
  • Presence of a pacemaker
  • Current treatment with testosterone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 1, 2025

First Posted

January 9, 2026

Study Start

January 3, 2026

Primary Completion (Estimated)

June 20, 2029

Study Completion (Estimated)

July 1, 2029

Last Updated

January 9, 2026

Record last verified: 2025-12